Takeda Pharmaceutical
TAK
$13.02
Share price
-0.38%
Change (1 day)
-22.82%
Change (1 year)
Categories
Revenue for Takeda Pharmaceutical (TAK)
Revenue in 2023 (TTM): $29.34 B
According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM) is $29.34 B. In 2022 the company made a revenue of $29.59 B a decrease over the years 2021 revenue that were of $30.95 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Takeda Pharmaceutical from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $29.34 B | -0.84% |
| 2022 | $29.59 B | -4.39% |
| 2021 | $30.95 B | 2.58% |
| 2020 | $30.17 B | 1.6% |
| 2019 | $29.70 B | 83.95% |
| 2018 | $16.14 B | 1.53% |
| 2017 | $15.90 B | -0.65% |
| 2016 | $16.00 B | 5.55% |
| 2015 | $15.16 B | -5.81% |
| 2014 | $16.10 B | -3.44% |
| 2013 | $16.67 B | -13.39% |
| 2012 | $19.25 B | 4.01% |
| 2011 | $18.51 B | 12.73% |
| 2010 | $16.42 B | 5.78% |
| 2009 | $15.52 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 216.95% | 🇺🇸 USA |
 Novartis NVS | $51.01 B | 73.81% | 🇨🇭 Switzerland |
 Pfizer PFE | $58.49 B | 99.32% | 🇺🇸 USA |
 Amgen AMGN | $28.19 B | -3.95% | 🇺🇸 USA |
 Sanofi SNY | $50.35 B | 71.59% | 🇫🇷 France |
 Merck MRK | $60.11 B | 104.83% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $37.84 B | 28.96% | 🇬🇧 UK |
 Seagen
SGEN | $2.30 B | -92.16% | 🇺🇸 USA |
 Dr. Reddy's RDY | $3.28 B | -88.81% | 🇮🇳 India |